A
Abdulmajeed Alajlan
Researcher at University of British Columbia
Publications - 11
Citations - 343
Abdulmajeed Alajlan is an academic researcher from University of British Columbia. The author has contributed to research in topics: Medicine & Psoriasis. The author has an hindex of 4, co-authored 5 publications receiving 322 citations.
Papers
More filters
Journal ArticleDOI
Raman spectroscopy of in vivo cutaneous melanin.
TL;DR: The ability to acquire these unique in vivo melanin signals suggests that Raman spectroscopy may be a useful clinical method for noninvasive in situ analysis and diagnosis of the skin.
Journal ArticleDOI
Paradoxical hypertrichosis after laser epilation.
TL;DR: Postlaser hair removal hypertrichosis is a real but rare occurrence in the experience and there was a trend for this adverse effect to occur in darker skin phototypes (IV) and with black hair as compared with the unaffected comparison group.
Journal ArticleDOI
Transfer of vitiligo after allogeneic bone marrow transplantation
TL;DR: In this article, a patient with multiple myeloma developed generalized vitiligo within 3 months after allogeneic BMT from his HLA-matched sister with the same disease.
Journal ArticleDOI
Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Kristian Thestrup-Pedersen,Ranjit S. Parhar,Kaida Wu,Per-Anders Bertilsson,Brian F. Meyer,Sayeda Abu-Amero,Bo Hainau,Abdullah Aleisa,Abdullah Alfadley,Issam Hamadah,Abdulmajeed Alajlan,Khalid Al-Hussein,Futwan Al-Mohanna +12 more
TL;DR: It is suggested how skin-homing CD8+ T-lymphocytes from patients with early stage CTCL can suppress the in vitro growth of skin- homing CD4+ T,lymphocyte cell strains, indicating immune surveillance.
Journal ArticleDOI
A case of nail psoriasis improved with treatment by risankizumab
TL;DR: In this paper , a case of nail psoriasis improved with treatment by risankizumab, which is a highly selective agent that is primarily available for plaque psoriiasis and psoriatic arthritis.